High success rate in target discovery and screening
First written in FY2023. . Latest entry: FY2025.
No other company in this theme has enough history to compare yet.
- FY2025Success Rates UpdatedAnnual report
「As a result, the success rate for target discovery was approximately 98% and the screening success rate was approximately 96%. Overall, hit compounds were obtained with an approximately 94% success rate from selection of the mRNAs targeted for drug discovery, as of the end of December 2025.」
The performance figures were updated from approximately 97%, 98% and 95% at the end of 2023 to approximately 98%, 96% and 94%, respectively, at the end of 2025 for target discovery, screening and overall success. - FY2023First statedAnnual report
「As a result, the success rate for target discovery was approximately 97%: multiple target structures were identified for 38 of 39 mRNAs. The screening success rate was approximately 98%: screenings were conducted against 49 target structures, and multiple hit compounds defined by the company were obtained in 48 screenings. Overall, hit compounds were obtained with an approximately 95% success rate from selection of the mRNAs targeted for drug discovery, as of the end of December 2023.」
The company reported its performance as of the end of December 2023 for target discovery, screening and hit-compound acquisition.